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FluoroCouncil Counterpoint to 
the Madrid Statement”
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Refers to http://dx.doi.org/10.1289/ehp.1509910
We commend the FluoroCouncil for phasing 
out long-chain poly- and perfluoroalkyl sub-
stance (PFAS) chemistry. However, members 
of the FluoroCouncil have been producing 
long-chain PFASs for decades while in pos-
session of research showing adverse health 
effects in humans and animals. This model of 
chemical manufacturing needs to change. We 
recommend implementing the principles of 
green chemistry (Anastas and Warner 1998) 
in chemical manufacturing to ensure safer and 
sustainable chemical products. The scientific 
consensus of the Madrid Statement authors 
and signatories is that the use of all PFASs is 
unsustainable, and can and should be greatly 
reduced and discontinued where feasible. 
Short-chain fluorinated alternatives were there-
fore intentionally included in the scope of the 
Madrid Statement.
Some of the functionalities provided by 
fluorotechnology have become part of mod-
ern life. However, we disagree that PFASs 
are critical to modern life. Sustainable and 
less hazardous alternatives are available for 
many functionalities, and others will be 
developed. PFAS-based chemistries are used 
in many nonessential applications such as 
clothing, sports equipment, food packaging 
materials, blooming and dispersion agents, 
and stain-repellant treatments. We urge the 
FluoroCouncil to provide as much infor-
mation as possible on the PFAS chemis-
tries used in different commercial products 
and technologies.
We are aware that short-chain perfluoro-
alkyl acids bioaccumulate less than long-
chain ones. However, some short-chain 
PFASs have been linked to adverse biological 
effects (Bull et al. 2014), and further sys-
tematic, representative studies on additional 
end points are needed. Given the ongoing 
release and environmental persistence of 
short-chain acids, increasing environmental 
and human exposures such as those docu-
mented by Glynn et al. (2012) are expected, 
for example, via contaminated drinking water 
aquifers (Xiao et al. 2015). Thus, continuous 
release of short-chain PFASs can be expected 
to lead to poorly reversible internal expo-
sures, regardless of their low bioaccumulation 
potential (Scheringer et al. 2014).
Bowman commented that the Madrid 
Statement cannot claim insufficient data on 
the hazards and risks of fluorinated alterna-
tives. However, Wang et al. (2015) high-
lighted the specific data gaps that prohibit 
conducting hazard and risk assessments for 
many fluorinated alternatives. An assess-
ment commissioned by the FluoroCouncil 
(ENVIRON International Corporation 
2014) also identified many gaps regarding 
human health data. 
Bowman stated that “decisions on the 
societal acceptability of strategic materi-
als such as PFASs cannot be wisely made 
on a single attribute such as persistence.” 
However, persistent chemicals are unsustain-
able in a world with limited resources. We 
cannot afford to “lose” portions of resources 
(water, soil, or food) because potentially 
harmful and persistent chemicals are accu-
mulating over centuries and causing continu-
ous exposure. Because of their persistence, 
an enormous inventory of PFASs is being 
created: Even if all PFAS production and 
uses were to stop immediately, PFASs would 
continue to be released for decades during 
products’ use and disposal life-cycle phases 
(Wang et al. 2014a, 2014b). One of the 
12 principles of green chemistry is “design 
for degradation: chemical products should 
be designed so that at the end of their func-
tion they break down into innocuous deg-
radation products and do not persist in the 
environment” (Anastas and Warner 1998). 
We endorse this principle and urge the 
FluoroCouncil to follow it also. 
We welcome collaboration with the 
FluoroCouncil to establish information-
sharing platforms for PFASs and support 
all opportunities for dialogue. We ask the 
FluoroCouncil to take leadership and respon-
sibility for the global management of the 
PFASs they produce, from  manufacturing to 
end of life.
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The FluoroCouncil’s voluntary develop-
ment of alternative chemistries is unprece-
dented and a model for the development 
and introduction of more sustainable 
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chemistry worldwide. More than a decade 
ago, the FluoroCouncil member companies 
responded to concerns about long-chain 
poly- and perfluoroalkyl substances (PFASs) 
by working with regulators to voluntarily 
phase out those substances and develop alter-
natives with improved health and environ-
mental profiles. The FluoroCouncil also 
works with regulators and other stakehold-
ers to support a global transition away from 
long-chain PFASs. This effort stands as a 
historic collaboration by government and 
industry to foster sustainable development.
The claim that all PFASs are  problematic 
is simply not supported by the wealth 
of data available on both long- and short-
chain PFASs. Because of the concerns raised 
in regard to long-chain PFASs, the U.S. 
Environmental Protection Agency (EPA) has 
held the fluorotechnology industry to high 
standards and increased data requirements 
to ensure the alternatives are well studied 
and safer than the substances being replaced. 
Consequently, short-chain PFASs are some 
of the most robustly studied new chemicals 
introduced to the market, having undergone 
years of toxicity and environmental testing 
at the request of regulators. Industry con-
tinues this collaboration with regulators, 
developing additional data on the alternatives 
and working to make those data publicly 
available, including on the FluoroCouncil 
website (http://www. fluorocouncil.org/
Resources/Research). Based on this robust 
body of data, regulators globally have deter-
mined the alternatives are safe for their 
intended use. The “sustainable and less haz-
ardous alternatives” sought by the Madrid 
Statement authors already exist in the form of 
short-chain PFASs.
We continue to be perplexed by asser-
tions from the authors of the Madrid 
Statement that short-chain PFASs present 
hazards comparable to those of long-chain 
PFASs, citing publications such as Bull et al. 
(2014) and Wang et al. (2015). These publi-
cations suffer from important data gaps, such 
as the failure to cite key published articles 
on the toxicity of short-chain PFASs (e.g., 
Klaunig et al. [2015], which presents ani-
mal data indicating perfluorohexanoic acid is 
not carcinogenic). Furthermore, these pub-
lications actually acknowledge or demon-
strate that many of the leading short-chain 
PFASs are less bioaccumulative and less toxic 
than the long-chain PFASs with which they 
have been compared, based on the avail-
able data taken as a whole. This conclusion, 
which is well accepted by regulatory agencies 
such as the EPA, compels a different policy 
outcome than the Madrid Statement sug-
gests. The first priority for risk management 
should be phase-out of the long-chain PFASs. 
Attempting to broaden that phase-out to 
effective alternatives that are less hazardous 
can only create a technological impasse that 
supports the retention of long-chain PFASs 
in the marketplace.
The authors of the Madrid Statement also 
contend that PFASs are not critical to mod-
ern life. The importance of PFAS chemis-
try, however, was long ago determined by the 
market. Industries relying on PFASs evaluated 
fluorinated and nonfluorinated alternatives, 
as well as alternative technology, and decided 
on the products that met their specifications 
and performance needs. Some decisions 
involved continuing to use PFASs because 
they meet performance needs that nonflu-
orinated alternatives cannot. For example, 
first-responder protective gear is treated with 
fluorinated products to help maintain per-
formance in fires; firefighting foam produced 
with fluorinated surfactants provides shorter 
extinguishment times and critical burnback 
resistance when fighting flammable liquid 
fires; and hospital gowns, drapes, and divider 
curtains rely on fluorinated polymers to pro-
vide protective barriers against transmission 
of diseases. Because the short-chain PFASs 
have been reviewed and approved by regula-
tory authorities globally, all applications rely-
ing on these substances can be used without 
 presenting a significant risk.
The largest use of short-chain PFASs is 
for polymeric products. These products—
like other polymers—are quite stable under 
environmental conditions. The resilience 
of short-chain PFASs is directly connected 
to its performance, providing long-lasting, 
durable properties. First responders, medical 
personnel, and patients would certainly not 
want the properties in safety gear or medi-
cal garments to quickly become ineffective. 
Even when the short-chain PFASs, which 
do not present a significant risk, are used 
in what some people may characterize as 
“nonessential applications,” such as clothing 
and furniture, these substances significantly 
extend the effective lifetime of those prod-
ucts, meaning less waste, infrequent wash-
ings, and economic savings. These benefits of 
short-chain PFASs can be further enhanced 
by reducing emissions through the adoption 
of best environmental practices, which the 
FluoroCouncil has identified and is encour-
aging in the supply chain. 
The FluoroCouncil members remain 
committed to science-based stewardship 
activities, including continually enhancing 
the sustainability of their chemistries and 
products by improving their environmen-
tal, health, safety, and performance profiles. 
We are open to working collaboratively and 
constructively with stakeholders on 1) strate-
gies to complete the global transition away 
from long-chain PFASs, 2) identification of 
issues that warrant further data development 
and risk assessment, 3) actions that can foster 
additional stewardship activities within the 
supply chain, and 4) best methods for trans-
parently sharing information relevant to the 
health and environmental impact of PFASs. 
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